Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
GASEC 20/MG CAP 14/CAP
- Sku : I-002462
Key features
GASEC 20 mg gastro-resistant hard capsules contain the proton pump inhibitor omeprazole 20 mg. It irreversibly inhibits the gastric parietal cell H+/K+-ATPase (proton pump), blocking the final step of acid secretion and reducing basal and stimulated gastric acid output. GASEC is indicated for gastroesophageal reflux disease (GERD), duodenal and gastric ulcers, Helicobacter pylori eradication as part of combination therapy, Zollinger-Ellison syndrome, NSAID-associated gastric ulcer treatment and prevention, and erosive esophagitis. Available by prescription in packs of 14 gastro-resistant hard capsules.- Brand: GASEC
- Active Ingredient: OMEPRAZOLE 20mg
- Strength: 20mg
- Dosage Form: Gastro-resistant capsule, hard
- Pack Size: 14 Capsules
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Proton Pump Inhibitors
- Drug Class: Proton Pump Inhibitor (PPI)
- Manufacturer: ALPHA PHARMA INDUSTRY
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 2004257245
- Shelf Life: 36 months
- Storage: store below 25°c
- Gi Condition: Acid Reflux/GERD, Ulcer
Frequently bought together
Indications
Approved Uses
Gastroesophageal reflux disease (GERD), duodenal ulcer, gastric ulcer, Helicobacter pylori eradication (in combination therapy), Zollinger-Ellison syndrome, NSAID-associated gastric ulcer treatment and prevention, erosive esophagitis
Dosage & Administration
Dosing by Condition
GERD (symptomatic): 20 mg once daily for 2-4 weeks; may extend to 4-8 weeks if needed. Erosive esophagitis: 20 mg once daily for 4-8 weeks (some patients may require 40 mg daily depending on severity). Duodenal ulcer: 20 mg once daily for 4 weeks. Gastric ulcer: 20 mg once daily for 4-8 weeks (40 mg daily may be used in some regimens/severe disease). H. pylori eradication: 20 mg twice daily as part of combination therapy (commonly 10-14 days depending on regimen). NSAID-associated ulcer treatment: 20 mg once daily for 4-8 weeks; prevention: 20 mg once daily. Zollinger-Ellison syndrome: initial 60 mg once daily, titrate; doses >80 mg/day in divided doses (up to ~120 mg/day or higher per specialist).
Initial Dose
20mg once daily
Maintenance Dose
10-40mg once daily, depending on the condition.
Maximum Dose
Doses up to 120mg three times daily have been administered for pathological hypersecretory conditions.
Children's Dosage
Children 1 year of age and older-Dose is based on body weight and must be determined by your doctor. The dose is usually 5 to 20 mg once a day before a meal.
How to Take
Take orally on an empty stomach, ideally 30-60 minutes before a meal (often before breakfast). Swallow the gastro‑resistant capsule whole with water; do not crush or chew. If unable to swallow, the capsule may be opened and the enteric-coated pellets/granules sprinkled on a small amount of soft acidic food (e.g., applesauce) or mixed with a slightly acidic liquid, swallowed immediately without chewing, and followed with water.
Safety & Warnings
Contraindications
Hypersensitivity to omeprazole/substituted benzimidazoles or excipients; concomitant use with nelfinavir; concomitant use with rilpivirine‑containing products.
Warnings & Precautions
Key warnings/precautions: symptomatic response may mask gastric malignancy (evaluate alarm features); long‑term use associated with hypomagnesemia, B12 deficiency, fractures and fundic gland polyps; risk of C. difficile diarrhea; acute interstitial nephritis; lupus erythematosus (incl. SCLE); consider interaction risks (e.g., clopidogrel/warfarin/antiretrovirals) and use lowest effective dose for the shortest duration.
Age Restriction
Not routinely recommended in infants <1 year for this 20 mg gastro‑resistant capsule; pediatric use requires age/weight‑appropriate formulations and specialist direction.
Drug Interactions
Drug Interactions
Key interactions include: clopidogrel (reduced activation/antiplatelet effect), warfarin (↑INR/bleeding risk), phenytoin and diazepam (↑levels via CYP2C19 inhibition), tacrolimus (↑levels), high‑dose methotrexate (↑levels/toxicity), nelfinavir and rilpivirine (contraindicated), atazanavir (reduced absorption/exposure), rifampin and St. John’s wort (reduced omeprazole exposure), and drugs needing acidic pH for absorption such as ketoconazole/itraconazole (reduced absorption).
Interaction Severity
MAJOR/CONTRAINDICATED: nelfinavir (avoid with omeprazole); rilpivirine-containing products (avoid with PPIs); atazanavir (avoid or only with specialist-directed adjustments-generally not recommended with PPIs). MAJOR/CLINICALLY SIGNIFICANT: clopidogrel (avoid omeprazole/esomeprazole when possible; consider alternative PPI such as pantoprazole if PPI needed). MODERATE: warfarin (monitor INR), high-dose methotrexate (consider temporary PPI interruption/monitor toxicity), tacrolimus (monitor levels), digoxin (monitor especially with hypomagnesemia risk), azole antifungals requiring acidity (reduced absorption).
Food Interaction
Take on an empty stomach, preferably 30-60 minutes before a meal (commonly before breakfast).
Special Populations
Pregnancy
Category C
Children
Children 1 year of age and older-Dose is based on body weight and must be determined by your doctor. The dose is usually 5 to 20 mg once a day before a meal.
Kidney Impairment
No adjustment needed.
Liver Impairment
Severe hepatic impairment: consider dose reduction; maximum 20 mg once daily is commonly recommended. Mild-moderate impairment: usually no adjustment.
Storage & Patient Advice
Stopping the Medicine
Do not stop long‑term therapy abruptly without a plan; rebound acid hypersecretion can occur-taper or step‑down is reasonable for prolonged use.
Patient Counseling
Take 30-60 minutes before a meal (often breakfast) and swallow the capsule whole; do not crush/chew. If you cannot swallow it, you may open the capsule and swallow the pellets with a small amount of soft acidic food/liquid without chewing. Full benefit may take 3-4 days. Seek care for severe/persistent diarrhea, signs of allergy/serious rash, or symptoms of low magnesium (muscle cramps, palpitations, seizures) with long-term use; tell your clinician about clopidogrel, warfarin, antiretrovirals (e.g., rilpivirine/atazanavir/nelfinavir), or high-dose methotrexate.
Monitoring Requirements
Long-term therapy: consider serum magnesium (especially if >3 months and/or with diuretics or digoxin), and consider vitamin B12 with prolonged use (e.g., >1 year) or risk factors; monitor for C. difficile-associated diarrhea if persistent diarrhea occurs; monitor renal function if signs of acute interstitial nephritis; if on warfarin, monitor INR when starting/stopping or changing dose.
Pharmacology
Mechanism of Action
Irreversibly inhibits the gastric parietal cell H+/K+-ATPase (proton pump), blocking the final step of acid secretion and reducing basal and stimulated gastric acid output.
Onset of Action
Acid suppression begins within about 1 hour after a dose, but maximal effect typically requires ~3-4 days of once-daily dosing.
Duration of Effect
Up to 24 hours
Half-Life
Approximately 0.5-1 hour (about 1 hour) for omeprazole plasma elimination half-life
Bioavailability
Approximately 35-40% after a single dose, increasing to about 60% with repeated dosing.
Metabolism
Extensive hepatic metabolism primarily via CYP2C19 and CYP3A4
Protein Binding
Approximately 95% (high protein binding, ~95%)
Product Information
Available Dosage Forms
For this PRODUCT (GASEC 20MG): gastro-resistant capsule, hard (oral). In general for omeprazole: delayed-release/gastro-resistant capsules or tablets, powder/granules for oral suspension; IV omeprazole exists in some markets but is not a dosage form of this specific registered product.
Composition per Dose
Each gastro-resistant capsule: 20mg omeprazole
Generic Availability
Yes
OTC Alternatives
OTC alternatives for mild/intermittent symptoms include antacids (e.g., aluminum/magnesium hydroxide, calcium carbonate) and H2-receptor antagonists (e.g., famotidine). Note: this specific product is prescription-only per verified API data.
Gi Condition
Acid Reflux/GERD, Ulcer
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)













